Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

78.40
BATS BZX Real-Time Price
As of 3:25pm ET
 -0.78 / -0.98%
Today’s Change
68.25
Today|||52-Week Range
131.95
-10.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.1B

Company Description

BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Contact Information

BioMarin Pharmaceutical, Inc.
770 Lindaro Street
San Rafael California 94901
P:(415) 506-6700
Investor Relations:
(415) 455-7558

Employees

Shareholders

Mutual fund holders64.45%
Other institutional37.81%
Individual stakeholders1.81%

Top Executives

Jean-Jacques BienaiméChairman & Chief Executive Officer
Brian R. MuellerChief Financial Officer & Executive Vice President
Eduardo E. Von PervieuxChief Information Officer
Henry J. FuchsPresident-Worldwide Research & Development
Steve MaricichMedical Director-Clinical Sciences